Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin by Favre-Bonté, Sabine et al.
Journal of Antimicrobial Chemotherapy (2003) 52, 598–604
DOI: 10.1093/jac/dkg397
Advance Access publication 1 September 2003
598
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
© The British Society for Antimicrobial Chemotherapy 2003; all rights reserved.
Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL     
cell-to-cell signal and inhibition by azithromycin
Sabine Favre-Bonté*, Thilo Köhler and Christian Van Delden†
Department of Genetics and Microbiology, University of Geneva, CMU, 1, rue Michel-Servet, CH-1211             
Geneva 4, Switzerland
Received 6 February 2003; returned 6 April 2003; revised 19 June 2003; accepted 30 June 2003
Objectives: In Pseudomonas aeruginosa, biofilm formation is controlled by a cell-to-cell signalling circuit
relying on the secretion of 3-oxo-C12-HSL and C4-HSL. Previous studies suggested that C4-HSL plays no
significant role in biofilm formation. However the wild-type PAO1 strain PAO-BI, used as a control in these
studies is itself impaired in the production of C4-HSL. We wondered therefore whether the role of C4-HSL in
biofilm formation might have been underestimated, and whether azithromycin inhibits biofilm formation by
interfering with cell-to-cell signalling.
Methods: We used isogenic mutants of wild-type PAO1 strains PAO-BI and PT5 in a static biofilm model.
Biofilm formation was quantified using Crystal Violet staining and exopolysaccharide measurements.
Results: Wild-type strain PAO-BI, as a result of its reduced C4-HSL secretion, produced 40% less biofilm com-
pared with the wild-type PAO1 strain PT5. Using isogenic mutants of strain PT5 we have shown that whereas
a lasI mutant (deficient in 3-oxo-C12-HSL) produced similar amounts of biofilm to the wild-type, a rhlI mutant
(deficient in C4-HSL) produced 70% less biofilm. In the latter strain, biofilm formation could be restored by
addition of exogenous C4-HSL. Azithromycin, known to reduce the production of both 3-oxo-C12-HSL and
C4-HSL, inhibited biofilm formation of wild-type PT5 by 45%. This inhibition could be reversed by the addition
of both cell-to-cell signals.
Conclusions: Our results indicate that C4-HSL also plays a significant role in biofilm formation. Furthermore,
we demonstrate the potential of using cell-to-cell signalling blocking agents such as azithromycin to inter-
fere with biofilm formation.
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Introduction
The opportunistic pathogen Pseudomonas aeruginosa is responsible
for severe ventilator-associated pneumonia (VAP) in intubated
patients. In these patients, colonization of the upper respiratory tract
by P. aeruginosa, which almost always precedes pneumonia, is
related to the presence and duration of an endotracheal intubation.
The colonization of inert surfaces by P. aeruginosa requires a sessile
bacterial growth pattern, called a biofilm.1 The acyl homoserine lactone
based cell-to-cell signals (autoinducers, AHLs) 3-oxo-C12-HSL and
C4-HSL participate in a cell-to-cell signalling (quorum-sensing)
regulatory network that controls the production of several extra-
cellular virulence factors and are important for biofilm formation.2
Synthesis of these molecules depends on two autoinducer-synthase
genes, lasI and rhlI, respectively.2 Both AHLs are produced in vitro
by P. aeruginosa isolates from chronically infected cystic fibrosis
(CF) patients,3 ex vivo in sputum from CF patients infected by
P. aeruginosa,4 as well as in lungs of mice chronically infected by
P. aeruginosa.5 AHLs have been detected in situ on urethral catheters
and in vitro using a P. aeruginosa biofilm model,6 as well as in lung
secretions of CF patients.7,8 Based on studies using the wild-type
PAO1 strain PAO-BI and its derived lasI mutant PAO-JP1, it has
been shown that 3-oxo-C12-HSL is required for biofilm different-
iation.9 Using the same strain PAO-BI, it was observed that the
autoinducer synthase gene lasI, required for 3-oxo-C12-HSL pro-
duction, is expressed in a large number of cells during the initial
phase of biofilm development and that this number decreases pro-
gressively over time.10 In contrast, rhlI, the autoinducer synthase
gene required for C4-HSL production, was expressed in fewer cells
but remained constant over time. Based on these observations, it has
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been suggested that C4-HSL might be of little importance in biofilm
formation.10 This is surprising as it has recently been shown that
ex vivo, P. aeruginosa isolates from CF patients grown in biofilm
produce higher amounts of C4-HSL compared with 3-oxo-C12-HSL.4
It has also been suggested that this AHL production pattern could be
used as a marker for P. aeruginosa growing in biofilm in CF patients.4
We have detected AHLs in situ directly in the lung tissue of CF
patients infected by P. aeruginosa and found a similar elevated
C4-HSL/3-oxo-C12-HSL ratio.11 Moreover, the rhl cell-to-cell signal-
ling system (dependent on the production of C4-HSL) has been
suggested to be important for survival of bacteria during the anaero-
bic biofilm mode of growth encountered in CF lung disease,12 and
rhamnolipids whose production is controlled by C4-HSL2 has been
shown to be required for the maintenance of biofilm architecture.13
Together, these observations suggest that C4-HSL might be more
important for biofilm formation than previously thought.
It has been recently understood that wild-type PAO1 strains from
various laboratories might differ in cell-to-cell signal production.14 In
particular, strain PAO-BI produces less C4-HSL than other PAO1
strains.14 We have recently described that the macrolide antibiotic
azithromycin inhibits virulence factor production of P. aeruginosa
by interfering with the cell-to-cell signalling circuit.15 We wondered
whether the reduced production of C4-HSL by strain PAO-BI might
have affected previous biofilm studies using this strain as a control
strain, and whether azithromycin affects biofilm formation by inter-
fering with AHL production.
Materials and methods
Media, antibiotics and strains
Unless otherwise stated, bacteria were freshly streaked from frozen
stocks onto LB-agar medium supplemented with antibiotics when
appropriate. Liquid LB cultures, containing antibiotics when appropriate,
were grown overnight at 37°C with agitation (250 rpm). Minimal AP
medium supplemented with 0.3 M NaCl was used for biofilm growth
experiments.16 Antimicrobials were supplied at the following concen-
trations: gentamicin (15 mg/L), tetracycline (50 mg/L), mercury chloride
(12.5 mg/L). All chemicals and antimicrobials were purchased from
Sigma, except azithromycin which was kindly provided by Pfizer. The
bacterial strains and their genetic linkage are presented in Table 1. To
construct strain PT918 (PAO-BI mexE::ΩHg), the mexE::ΩHg mutation
from strain PT12117 was transferred by transduction using phage
E79tv218 into strain PAO-BI.
Autoinducer measurements
For extraction of autoinducers from liquid cultures, bacterial strains were
grown in LB medium until they reached stationary phase (6 h). Aliquots
of filtered culture supernatants were subjected to two extractions by add-
ition of one volume of acidified ethyl acetate (0.01% acetic acid). For
extraction of autoinducers from biofilms, polyvinyl chloride (PVC)
fragments on which biofilms had been formed were rinsed three times
and immersed into 1 mL of 0.9% NaCl. One volume of acidified ethyl
acetate was added and the mixture incubated in closed tubes at 4°C over-
night. A second extraction was carried out for 1 h, and the two extracts
were pooled. The extracted autoinducers were quantified using specific
bioassays using E. coli MG4λI14 (pPCS1) for 3-oxo-C12-HSL and
P. aeruginosa PAO-JP2 (pECP61.5) for C4-HSL as reporter strains.19β-Galactosidase (β-gal) activity was determined as previously described.20
Static biofilm formation assay
Sterile PVC strips of approximately 1 cm2 were cut from original
endotracheal devices (Mallinckrodt Inc., St Louis, MO, USA) and biofilm
was allowed to develop under static conditions for 3 days as previously
described.21 All PVC strips were weighed and experiments were standard-
ized by weight. Bacterial strains were grown in LB medium for 6 h with
agitation at 37°C. PVC strips were immersed in the bacterial culture
medium for 1 h without agitation to allow bacteria to adhere. PVC strips
were then transferred into AP medium and incubated for 3 days without
agitation at 37°C. Azithromycin (2 mg/L) and/or autoinducers (10 µM
each, once a day) were added as indicated. After the 3 day incubation
period, the PVC strips were individually washed twice in 0.9% NaCl and
subjected to biofilm measurements (see below). We had previously
observed that initial growth of wild-type PT5 was slightly retarded in the
presence of 2 mg/L azithromycin when grown under agitation in liquid
media.15 This effect was restricted to early and mid-exponential growth
phases, when quorum sensing is not yet active. In order to determine
Table 1. Bacterial strains and plasmids used in this study
Strain Relevant characteristics Source or reference
E. coli
MG4λI14 λ lysogen carrying a chromosomal 
lasI::lacZ fusion
40
P. aeruginosa
PAO-BI PAO1 wild-type (nfxC) 14
PAO-JP1 PAO-BI (nfxC, ∆lasI) 41
PT918 PAO-BI (nfxC, mexE::ΩHg) this study
PDO100 PAO1 (rhlI::Tn501) 42
PAO-JP2 PDO100(∆lasI) 41
PT5 PAO1 wild-type 14
PT466 PT5(∆lasI) 18
PT454 PT5(∆rhlI) 18
PT502 PT5(∆lasI, ∆rhlI) 31
Plasmids
pECP61.5 rhlA′-lacZ transcriptional fusion 41
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whether this small delay could affect final growth in our 3 day static bio-
film assay, we measured colony forming units (cfu) of strain PT5 grown
without agitation after 3 days in the biofilm medium in the presence and
absence of 2 mg/L azithromycin. Azithromycin did not affect the number
of viable counts of wild-type strain PT5.
Crystal Violet staining and exopolysaccharide determinations
PVC strips, on which biofilm had developed, were incubated for 15 min
in a Crystal Violet staining solution (0.1% in distilled water),22 and
washed three times in distilled water. The stain was then dissolved in
ethanol and absorbance was measured at 570 nm as previously described.22
Exopolysaccharide determinations were carried out by total carbohy-
drate assays.23 PVC strips were washed in 0.9% NaCl, and incubated in
an equal volume of 5% phenol to which 5 volumes of H2SO4 containing
hydrazine sulphate was added. The mixture was incubated for 1 h in the
dark and absorbance was measured at 490 nm.
Results and discussion
Role of C4-HSL and 3-oxo-C12-HSL in total biofilm formation
Most in vitro studies have investigated the potential role of cell-to-
cell signals in the formation of P. aeruginosa biofilm using a continuous
flow system.9,10,24,25 In such bioreactors a constant medium flux
brings new nutrients and eliminates metabolic products. These
experimental conditions are therefore very different from in vivo situ-
ations such as biofilm formation on endotracheal intubation devices.
Indeed the bacteria growing inside the secretions that accumulate
above the cuff of intubation devices are in static growth conditions
without regular change of their growth medium. We therefore
decided to adopt a static in vitro biofilm model21 using sterile PVC
strips derived from original intubation devices. Previous experi-
ments, using continuous flow systems, have shown that the total
amount of biofilm formed by the lasI mutant PAO-JP1 is not reduced
compared with its parent strain.9,25 As experimental conditions
greatly influence biofilm formation,25 we first compared biofilm for-
mation by mutant PAO-JP1 and its parent strain the PAO1 wild-type
strain PAO-BI in our static biofilm assay. Biofilm measurements
using Crystal Violet staining gave similar results for both strains
(Figure 1a), confirming that the lasI mutation does not affect total
biofilm for-mation in our biofilm model.
In previous studies, strain PAO-BI and its derived lasI mutant
PAO-JP1, as well as the non-nfxC rhlI mutant PDO100, have been
used to determine the respective roles of autoinducers in biofilm for-
mation.9,10,24,25 Such studies have suggested that C4-HSL does not
play a significant role in biofilm formation.9,10 However, we have
recently shown that strain PAO-BI bears the nfxC mutation.14 This
mutation leads to overexpression of the MexEF-OprN multidrug
efflux system, and to resistance towards quinolones, chloramphenicol,
trimethoprim and tetracycline. More importantly, this mutation also
leads to a reduction in rhlI expression, responsible for lower C4-HSL
production, compared with the non-nfxC wild-type PAO1 strain
PT5.14 Therefore, we wondered whether the reduced expression of
rhlI by strains PAO-BI and PAO-JP1 might have led to an under-
estimation of the role of C4-HSL in biofilm formation. In accordance
with a recent report,24 we have shown that the rhlI mutant PDO100
formed slightly less biofilm compared with strain PAO-BI (Figure
1a). More importantly, strain PAO-BI only produced 60% of the total
biofilm compared with wild-type PT5 (Figure 1a), suggesting that
overexpression of the MexEF-OprN multidrug efflux system reduces
the biofilm production of strain PAO-BI. In order to confirm this
result we deleted the mexE gene that encodes the membrane fusion
protein of the MexEF-OprN efflux pump17 in strain PAO-BI to obtain
mutant PT918. Such a deletion leads to complete inactivation of the
MexEF-OprN efflux system, therefore suppressing the phenotype
associated with pump overexpression.14 When tested in our static
biofilm model, mutant PT918 was completely restored in biofilm for-
mation to wild-type PT5 levels (Figure 1a). We also measured C4-
HSL production in culture supernatants of strains PT5, PAO-BI and
PT918 by a specific bioassay. C4-HSL production, reduced by 50%
in strain PAO-BI, was restored to strain PT5 levels by the inactivation
of the MexEF-OprN efflux system in strain PAO-BI (Table 2). These
results confirm that the nfxC mutation is responsible for a reduction
in biofilm formation by strain PAO-BI resulting from decreased
C4-HSL production.
In order to determine the role of C4-HSL during biofilm formation,
we decided to compare the total biofilm formed by wild-type PT5 and
its derived lasI (PT466), rhlI (PT454), and lasI/rhlI (PT502) mutants.
First, the production of C4-HSL was measured in the culture super-
natants of these mutants. Some reduction in C4-HSL production can
be expected in a lasI mutant as the las quorum-sensing system con-
trols the transcription of rhlR, itself required for optimal C4-HSL
production.26 Indeed the C4-HSL production of the lasI mutant
PT466 was reduced by 55% compared with its parent strain, probably
as a result of the las/rhl hierarchy. The lasI mutant PAO-JP1 was
even more severely affected and produced only 2.5% compared with
its parent strain and 1.5% compared with strain PT5 (Table 2). As
expected, culture supernatants of mutants PT454, PT502 and
PDO100 contained no detectable C4-HSL (Table 2).
When biofilm production was assessed, the lasI mutant PT466
produced slightly more biofilm than strain PT5 (Figure 1b). In con-
trast, the biofilm formed by the rhlI mutant PT454 was reduced by
70% compared with its parent strain (Figure 1b), correlating with the
reduction in biofilm formed by the rhlI mutant PDO100 (Figure 1a).
Furthermore, the double lasI/rhlI mutant PT502 formed a similar
amount of biofilm as the rhlI mutant PT454 (Figure 1b). These results
indicate that C4-HSL is required for full biofilm formation. To con-
firm this hypothesis, we complemented mutant PT454 by adding
exogenous C4-HSL during the biofilm formation assay. As shown in
Figure 1(b), addition of exogenous C4-HSL partially restored the
biofilm formation of rhlI mutant PT454 from 30% to 65% of the
wild-type PT5 level. Similarly, in the presence of both exogenous
AHLs, the biofilm formed by mutant PT502 increased from 30% to
75% of the PT5 level (Figure 1b). The lack of complete complemen-
tation of both mutants through addition of a constant concentration of
exogenous autoinducers to the biofilm assay is likely to result from
suboptimal AHL concentrations as these vary both in time and space
during biofilm formation.10 We do not believe that secondary mutations
in vfr and algC in our cell-to-cell signalling mutants could be respon-
sible for the lack of complete complementation. Mutations in these
genes affect twitching motility, which is cell-to-cell signalling in-
dependent.27,28 As twitching motility did not differ between parent
strain PT5 and its derived cell-to-cell signalling mutants PT466,
PT454 and PT502 (data not shown), such secondary mutations are
unlikely to have occurred in our strains.
These results clearly demonstrate that, at least under our experi-
mental conditions, C4-HSL is required for optimal biofilm formation
by P. aeruginosa. Indeed it appears that a previously undiscovered
reduced expression of rhlI, leading to lower C4-HSL production, in
the wild-type strain PAO-BI, is responsible for an underestimation of
the role of this autoinducer in biofilm formation. The importance of
C4-HSL is indeed not visible when PAO-BI is used as the control
Inhibition of cell-to-cell signalling by azithromycin
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strain,9 or when carrying an rhlI reporter fusion.10 In contrast, the
importance of this autoinducer becomes apparent when both the
parent and the rhlI mutant do not overexpress the MexEF-OprN
efflux system. These results correlate well with the recent obser-
vation that the rhl system is activated during the maturation stage of
biofilm development.29 It appears that while the las system (LasR/
3-oxo-C12-HSL) is essential for biofilm differentiation,9 and plays a
role during the irreversible attachment stage,29 the rhl system (RhlR/
C4-HSL) also plays an important role.
The finding that P. aeruginosa strains overexpressing the MexEF-
OprN multidrug efflux system are impaired in biofilm formation is
interesting. Such strains can be selected during quinolone treatment
in an animal model,30 and are less virulent in a rat model of acute
pneumonia.31 Whether such multidrug-resistant isolates could be
selected during antimicrobial treatment of CF patients, and affect the
evolution of the disease deserves further investigation.
Azithromycin inhibits biofilm formation by reducing 
cell-to-cell signalling
The potential clinical value of antibacterials that would control
and/or prevent P. aeruginosa infections by interfering with cell-
to-cell signalling has recently been underlined.2,32 The macrolide
antibiotic azithromycin is neither bactericidal nor bacteriostatic
against P. aeruginosa (MIC 64–128 mg/L) at achievable tissue con-
centrations (1–4 mg/L).33,34 However, even at low concentrations
(1–2 mg/L) azithromycin reduced the adherence of P. aeruginosa to
polystyrene,35 as well as the production of exopolysaccharides by
P. aeruginosa, and has therefore been suggested to inhibit biofilm
Figure 1. (a) Biofilm formation in wild-type Pseudomonas aeruginosa and AHL-deficient mutants. (b) Effects of AHLs on biofilm formation.
S. Favre-Bonté et al.
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formation.36 We have recently shown that 2 mg/L azithromycin
inhibits the production of both 3-oxo-C12-HSL and C4-HSL by P.
aeruginosa.15 In view of the above presented results we wondered
whether azithromycin inhibits biofilm formation by interfering with
autoinducer synthesis. In the presence of 2 mg/L azithromycin, the
biofilm formed by strain PT5 was reduced by 45% as quantified by
Crystal Violet staining (Figure 2a). This decrease was associated
with a 50% reduction in exopolysaccharide production as measured
by the total carbohydrate assay. In contrast 2 mg/L azithromycin did
not affect biofilm production by mutant PT502 (27% of wild-type in
the absence versus 25% in the presence of 2 mg/L azithromycin),
suggesting that azithromycin exerts its effect on biofilm formation
via inhibition of cell-to-cell signalling.
In order to confirm that azithromycin reduced the production of
both AHLs in the biofilm, we directly extracted and measured both
AHLs from strain PT5 biofilms grown on PVC strips in the absence
and presence of 2 mg/L azithromycin. As expected, both 3-oxo-C12-
HSL and C4-HSL were severely reduced in the presence of the
macrolide (Figure 2b). Addition of both AHLs in the presence of
azithromycin restored the amount of biofilm formed to 85% of the
initial levels observed in the absence of azithromycin as measured by
Crystal Violet staining, and to 80% as measured by exopolysaccharide
production (Figure 2a). Taken together, these results indicate that
2 mg/L azithromycin inhibits the production of biofilm by wild-type
PT5 in our biofilm model at least partially by interfering with the pro-
duction of the two autoinducers. As 3-oxo-C12-HSL is required for
biofilm differentiation,9 it is likely that azithromycin, by reducing
both C4-HSL and 3-oxo-C12-HSL formation, leads not only to a
reduction in the total amount of biofilm formed, but also affects its
differentiation. It has been recently described that rhamnolipid sur-
factant is important for the maintenance of biofilm architecture by
maintaining open channels within the biofilm structure.13 Moreover
the rhl cell-to-cell signalling system has been suggested to protect
P. aeruginosa strains growing inside biofilms by controlling the pro-
duction of nitrite reductase essential for the detoxification from NO
produced during growth in anaerobic conditions.12 Both these
functions are dependent on the adequate production of C4-HSL.2 It
appears therefore that azithromycin by reducing cell-to-cell signal
production not only reduces the production of extracellular virulence
factors such as elastase,15 but also interferes with biofilm formation at
different levels. This could be particularly useful in clinical situa-
tions, such as cystic fibrosis,4,11 and colonization of intubation
devices in which growth in biofilm might play an important role. The
recent encouraging results obtained in CF patients treated with
azithromycin37–39 might therefore not only be the result of the
suggested anti-inflammatory effect of this macrolide, but also
because of its cell-to-cell signalling blocking activity. These results
support the need for active research to develop more efficient cell-to-
cell signalling blockers that could, according to the results presented
here, reduce P. aeruginosa biofilm formation on medical devices
such as endotracheal intubation devices.
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Table 2. Concentration of C4-HSL in culture 
supernatants of P. aeruginosa cell-to-cell signalling 
mutants after 6 h of growth in LB medium
P. aeruginosa strains C4-HSL (µM)
PT5 10.24 ± 0.51
PT466 (nfxC∆lasI) 4.41 ± 1.6
PT454 (∆rhlI) <10–3
PT502 (∆lasI, ∆rhlI) <10–3
PAO-BI (nfxC) 5.57 ± 0.27
PAO-JP1 (nfxC, ∆lasI) 0.15 ± 0.02
PT918 (nfxC, mexE) 9.54 ± 0.31
PDO100 (∆rhlI) <10–3
Figure 2.
 Effect of azithromycin on (a) biofilm formation, determined by Crystal
Violet staining (diagonally striped bars) and exopolysaccharide production (white
bars) and (b) AHL production.
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